First Heartland Consultants Inc. Cuts Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

First Heartland Consultants Inc. decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,029 shares of the exchange traded fund’s stock after selling 299 shares during the period. First Heartland Consultants Inc.’s holdings in SPDR S&P Biotech ETF were worth $466,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. MinichMacGregor Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 2.1% during the 2nd quarter. MinichMacGregor Wealth Management LLC now owns 31,194 shares of the exchange traded fund’s stock valued at $2,892,000 after buying an additional 640 shares in the last quarter. Aries Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at about $234,000. Pettinga Financial Advisors LLC raised its position in shares of SPDR S&P Biotech ETF by 0.7% in the 2nd quarter. Pettinga Financial Advisors LLC now owns 26,633 shares of the exchange traded fund’s stock valued at $2,469,000 after purchasing an additional 193 shares during the last quarter. Moody Lynn & Lieberson LLC acquired a new stake in SPDR S&P Biotech ETF in the 2nd quarter worth approximately $2,735,000. Finally, Sterling Investment Counsel LLC grew its position in SPDR S&P Biotech ETF by 6.8% during the 2nd quarter. Sterling Investment Counsel LLC now owns 4,261 shares of the exchange traded fund’s stock worth $395,000 after purchasing an additional 273 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock traded down $0.01 during mid-day trading on Monday, reaching $101.50. 2,022,703 shares of the company traded hands, compared to its average volume of 10,023,470. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The firm’s fifty day moving average is $96.10 and its two-hundred day moving average is $93.25. The company has a market capitalization of $7.74 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.